1. Home
  2. MSBI vs OCS Comparison

MSBI vs OCS Comparison

Compare MSBI & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$32.59

Market Cap

667.4M

Sector

Finance

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$7.48

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSBI
OCS
Founded
1881
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
667.4M
732.4M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
MSBI
OCS
Price
$32.59
$7.48
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$33.25
★ $36.73
AVG Volume (30 Days)
128.6K
★ 291.2K
Earning Date
10-22-2026
11-03-2026
Dividend Yield
★ 4.15%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.56
N/A
Revenue
N/A
N/A
Revenue This Year
$1.94
N/A
Revenue Next Year
$0.71
$365.20
P/E Ratio
$20.39
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.24
$7.11
52 Week High
$35.10
$34.48

Technical Indicators

Market Signals
Indicator
MSBI
OCS
Relative Strength Index (RSI) 40.65 24.99
Support Level $29.78 N/A
Resistance Level $33.84 $13.49
Average True Range (ATR) 0.70 0.44
MACD -0.07 -0.04
Stochastic Oscillator 22.88 10.97

Price Performance

Historical Comparison
MSBI
OCS

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: